Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to 0.26.

  • Fortress Biotech's Debt Ratio fell 3621.83% to 0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26, marking a year-over-year decrease of 3621.83%. This contributed to the annual value of 0.4 for FY2024, which is 1063.38% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Debt Ratio is 0.26, which was down 3621.83% from 0.31 recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Debt Ratio peaked at 0.46 during Q2 2024, and registered a low of 0.1 during Q3 2021.
  • Over the past 5 years, Fortress Biotech's median Debt Ratio value was 0.3 (recorded in 2023), while the average stood at 0.28.
  • In the last 5 years, Fortress Biotech's Debt Ratio plummeted by 5712.74% in 2021 and then soared by 18782.89% in 2022.
  • Quarter analysis of 5 years shows Fortress Biotech's Debt Ratio stood at 0.11 in 2021, then soared by 187.83% to 0.31 in 2022, then increased by 16.55% to 0.36 in 2023, then rose by 10.63% to 0.4 in 2024, then crashed by 34.47% to 0.26 in 2025.
  • Its Debt Ratio was 0.26 in Q3 2025, compared to 0.31 in Q2 2025 and 0.32 in Q1 2025.